NDC 0002-4491

Reyvow

Lasmiditan

Reyvow is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Lasmiditan.

Product ID0002-4491_1ba572bf-50d9-45aa-b2fb-533be8ea0e38
NDC0002-4491
Product TypeHuman Prescription Drug
Proprietary NameReyvow
Generic NameLasmiditan
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-10-11
Marketing CategoryNDA / NDA
Application NumberNDA211280
Labeler NameEli Lilly and Company
Substance NameLASMIDITAN
Active Ingredient Strength100 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0002-4491-08

2 BLISTER PACK in 1 CARTON (0002-4491-08) > 4 TABLET in 1 BLISTER PACK
Marketing Start Date2020-01-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0002-4491-08 [00002449108]

Reyvow TABLET
Marketing CategoryNDA
Application NumberNDA211280
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-01-31

NDC 0002-4491-61 [00002449161]

Reyvow TABLET
Marketing CategoryNDA
Application NumberNDA211280
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
LASMIDITAN100 mg/1

NDC Crossover Matching brand name "Reyvow" or generic name "Lasmiditan"

NDCBrand NameGeneric Name
0002-4312Reyvowlasmiditan
0002-4491Reyvowlasmiditan
0002-4736Reyvowlasmiditan

Trademark Results [Reyvow]

Mark Image

Registration | Serial
Company
Trademark
Application Date
REYVOW
REYVOW
88035791 not registered Live/Pending
Eli Lilly and Company
2018-07-12
REYVOW
REYVOW
87446502 not registered Live/Pending
Eli Lilly and Company
2017-05-11
REYVOW
REYVOW
86926214 not registered Dead/Abandoned
ELANCO US INC.
2016-03-02
REYVOW
REYVOW
85685418 not registered Dead/Abandoned
Eli Lilly and Company
2012-07-24
REYVOW
REYVOW
85042374 not registered Dead/Abandoned
Eli Lilly and Company
2010-05-19
REYVOW
REYVOW
77141452 not registered Dead/Abandoned
Eli Lilly and Company
2007-03-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.